Compare PRGO & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRGO | PENN |
|---|---|---|
| Founded | 1887 | 1972 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2013 | 1996 |
| Metric | PRGO | PENN |
|---|---|---|
| Price | $16.09 | $14.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 20 |
| Target Price | $16.50 | ★ $24.13 |
| AVG Volume (30 Days) | 2.7M | ★ 2.8M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 7.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | $800,000.00 | ★ $6,362,900,000.00 |
| Revenue This Year | N/A | $6.65 |
| Revenue Next Year | $0.74 | $4.26 |
| P/E Ratio | ★ N/A | $67.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.23 | $11.65 |
| 52 Week High | $22.01 | $22.36 |
| Indicator | PRGO | PENN |
|---|---|---|
| Relative Strength Index (RSI) | 60.32 | 38.19 |
| Support Level | $13.55 | $13.86 |
| Resistance Level | N/A | $14.99 |
| Average True Range (ATR) | 0.66 | 0.54 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 75.87 | 3.24 |
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 42 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 81% of total sales in 2025; 19% was from the interactive segment, which includes sports, i-gaming, and media revenue. The retail portfolio generates low-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media asset, theScore, provides access to sports betting/i-gaming technology and clientele, helping it form a leading digital position.